Highlights of ASH in Asia-Pacific 2026 (Updated with Program)
Warm greetings from the Malaysian Society of Haematology (MSH)
We are delighted to announce that MSH will host the Highlights of ASH in Asia-Pacific 2026, in collaboration with the American Society of Hematology (ASH).
The event will take place at the Shangri-La Kuala Lumpur on April 10–11, 2026.
As ASH describes it:
“Highlights of ASH in Asia-Pacific brings global hematology leaders together for two days in Kuala Lumpur, Malaysia. Discuss the most influential and novel research from the latest ASH Annual Meeting, spanning a wide range of topics. Connect with top experts in person and learn how to apply the latest research to your own work.”
Registration is now open via the ASH website:
https://www.hematology.org/meetings/highlights-of-ash-in-asia-pacific
We look forward to welcoming haematology colleagues and researchers from around the region to Kuala Lumpur for two days of learning, collaboration, and discovery.
#MSH #Haematology #HighlightsOfASH #ASHinAsiaPacific #MedicalEducation #HematologyConference #KualaLumpur
Highlights of ASH Day 1 (Friday, April 10, 2026)
| Time | Session |
|---|---|
| 8:00 – 8:45 | Registration and Exhibits Open |
| 8:45 – 9:00 | Welcome & Introductions |
| 9:00 – 9:30 |
Changing Paradigms of Treatment Approaches for Acute Myeloid Leukemia
Katherine Tarlok, MD — University of Washington, Seattle
|
|
|
|
| 9:30 – 10:00 |
Integrating Approved Immunotherapies into Treatment Approaches for Adult B-Precursor Acute Lymphoblastic Leukemia
Adele K. Fielding, MBBS, PhD — Hull York Medical School, England
|
| 10:00 – 10:30 | Panel Discussion |
| 10:30 – 11:00 | Coffee Break (Exhibit Hall) |
| 11:00 – 11:45 |
From Bench to Bedside: Innovations in Hemoglobinopathy Treatment
Payal Desai, MD — Wake Forest University, USA
Prantar Chakrabarti, MBBS, MD, DNB, DM — Zoho for Healthcare, India |
| 11:45 – 12:15 |
Artificial Intelligence and Informatics in Hematology
Barbara Lam, MD — Fred Hutchinson Cancer Center, Seattle
|
| 12:15 – 12:45 | Panel Discussion |
| 12:45 – 2:00 | Lunch in Exhibit Hall (All Attendees) Lunch with the Experts (Ticketed) |
| 2:00 – 3:15 |
Tumor Board: Evolving Myeloma Treatment Paradigm
Gin Gin Gan, MD — Universiti Malaya, Kuala Lumpur
Shaji Kumar, MD — Mayo Clinic, Rochester Hang Quach, MBBS, MD — St Vincent's Hospital, Melbourne |
| 3:15 – 3:45 | Coffee Break (Exhibit Hall) |
| 3:45 – 4:15 |
Clinical Features and Management of Histiocytic Neoplasms in the Era of Targeted Therapies
Gaurav Goyal, MD — University of Alabama, Birmingham
|
| 4:15 – 4:45 |
Novel Insights and Emerging Therapies in Immune-Mediated Cytopenias
Michael A. Cole, MD, DPhil — Johns Hopkins Medicine, Baltimore
|
| 4:45 – 5:15 | Panel Discussion |
| 5:15 – 5:20 | Highlights of ASH Day 1 Closing Remarks |
Highlights of ASH Day 2 (Saturday, April 11, 2026)
| Time | Session |
|---|---|
| 8:00 – 8:45 | Registration and Exhibits Open |
| 8:45 – 9:00 | Welcome & Introductions |
| 9:00 – 9:30 |
New Frontiers in Bleeding Disorders
Ross Baker, MBBS — Perth Blood Institute, Perth, Australia
|
| 9:30 – 10:00 |
Hematology Through a Gender Lens: Unique and Underrecognized Challenges
Sarah O'Brien, MD, MSc — Nationwide Children's, Columbus, Ohio
|
| 10:00 – 10:30 | Panel Discussion |
| 10:30 – 11:00 | Coffee Break (Exhibit Hall) |
| 11:00 – 12:15 |
Turning the Tide: Key Cases and Conundrums in Thrombosis Medicine
Lai Heng Lee, MBBS, MD — Singapore General Hospital, Singapore
Ponlapat Rojnuckarin, MD, PhD — Bumrungrad International Hospital, Bangkok Jeffrey Weitz, MD — McMaster University, Ontario, Canada |
| 12:15 – 1:30 | Lunch in the Exhibit Hall (All Attendees) Lunch with the Experts (Ticketed) |
| 1:30 – 2:00 |
Updates in Management of Indolent Lymphoma and Chronic Lymphocytic Leukemia
Jia Ruan, MD, PhD — Weill Cornell Medicine, New York
|
| 2:00 – 2:45 |
Novel Treatment Strategies in Aggressive Lymphoma
Steven Park, MD — Wake Forest University, Winston-Salem
Eric Tse, MBBS, PhD — Hong Kong University, Hong Kong |
| 2:45 – 3:15 | Panel Discussion |
| 3:15 – 3:45 | Coffee Break (Exhibit Hall) |
| 3:45 – 4:30 |
New Horizons in Transplantation and Cellular Therapies in Asia and Beyond
Robert Negrin, MD — Stanford University, California
William Hwang, MBBS — National Cancer Centre & Singapore General Hospital |
| 4:30 – 5:00 |
Practice Changing Advances in Myelodysplastic Syndromes and Myeloproliferative Neoplasms
Harry Gill Singh, MBBS — HKU Med, Hong Kong
|
| 5:00 – 5:30 | Panel Discussion |
| 5:30 | Highlights of ASH in Asia-Pacific Closing Remarks |